KURN Income Statement - Kuros Biosciences AG - Alpha Spread

Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 22.25 CHF 12.26% Market Closed
Market Cap: 814.4m CHF
Have any thoughts about
Kuros Biosciences AG?
Write Note

Income Statement

Earnings Waterfall
Kuros Biosciences AG

Revenue
52.5m CHF
Cost of Revenue
-11m CHF
Gross Profit
41.6m CHF
Operating Expenses
-50.8m CHF
Operating Income
-9.2m CHF
Other Expenses
336k CHF
Net Income
-8.9m CHF

Income Statement
Kuros Biosciences AG

Rotate your device to view
Income Statement
Currency: CHF
Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
36
N/A
36
+0%
36
+0%
41
+14%
6
-85%
20
+220%
20
0%
21
+5%
22
+7%
9
-59%
9
N/A
24
+163%
22
-6%
22
0%
23
+2%
2
-92%
2
+2%
2
-19%
1
-22%
1
-3%
1
-7%
1
N/A
1
N/A
1
-9%
1
N/A
1
N/A
1
-47%
1
N/A
0
-49%
1
+161%
1
+89%
3
+90%
3
+15%
4
+37%
12
+193%
14
+17%
15
+10%
18
+19%
20
+14%
34
+64%
53
+57%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(2)
(2)
(4)
(4)
(4)
(4)
(7)
(5)
(11)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
+140%
1
+83%
2
+83%
1
-32%
2
+19%
8
+362%
10
+31%
11
+14%
14
+26%
13
-10%
28
+120%
42
+46%
Operating Income
Operating Expenses
(43)
(44)
(46)
(43)
(41)
(44)
(44)
(46)
(42)
(36)
(32)
(28)
(27)
(26)
(25)
(22)
(24)
(21)
(19)
(16)
(13)
(15)
(16)
(20)
(22)
(24)
(7)
(17)
(15)
(14)
(14)
(13)
(14)
(13)
(14)
(19)
(21)
(24)
(29)
(37)
(51)
Selling, General & Administrative
(5)
(6)
(6)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
(4)
(4)
(5)
(5)
(5)
(5)
(5)
(6)
(6)
(6)
(6)
(5)
(5)
(5)
(6)
(6)
(7)
(15)
(13)
(9)
(8)
(7)
(9)
(9)
(11)
(14)
(16)
(16)
(24)
(28)
(44)
Research & Development
(39)
(40)
(41)
(38)
(37)
(40)
(40)
(41)
(38)
(33)
(29)
(25)
(23)
(22)
(21)
(18)
(20)
(17)
(14)
(11)
(8)
(11)
(12)
(16)
(18)
(20)
(2)
(4)
(5)
(7)
(7)
(6)
(5)
(4)
(3)
(5)
(5)
(3)
(5)
(3)
(7)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
0
(0)
0
(1)
0
(1)
0
Other Operating Expenses
2
2
0
1
1
1
1
0
0
0
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
3
3
1
1
0
0
0
0
0
0
(5)
0
(6)
0
Operating Income
(7)
N/A
(8)
-22%
(10)
-20%
(2)
+84%
(35)
-2 080%
(24)
+32%
(24)
-2%
(25)
-1%
(20)
+19%
(27)
-35%
(23)
+15%
(4)
+81%
(5)
-4%
(4)
+15%
(2)
+45%
(20)
-847%
(22)
-7%
(20)
+9%
(18)
+11%
(15)
+14%
(12)
+20%
(14)
-13%
(14)
-7%
(19)
-31%
(21)
-10%
(23)
-12%
(7)
+70%
(16)
-134%
(15)
+7%
(14)
+9%
(13)
+3%
(11)
+14%
(12)
-9%
(12)
+6%
(7)
+42%
(9)
-30%
(10)
-11%
(10)
-2%
(16)
-58%
(9)
+44%
(9)
-7%
Pre-Tax Income
Interest Income Expense
(1)
(2)
(1)
(2)
(2)
(2)
(3)
(4)
(3)
2
6
9
9
2
(1)
(3)
(1)
1
8
8
5
3
(5)
(6)
(7)
(6)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(1)
(3)
(3)
(1)
(0)
2
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(4)
0
(5)
0
Total Other Income
(2)
(2)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(8)
N/A
(10)
-25%
(11)
-16%
(3)
+73%
(37)
-1 093%
(26)
+30%
(28)
-6%
(28)
-3%
(23)
+19%
(25)
-8%
(17)
+32%
4
N/A
4
-9%
(1)
N/A
(3)
-103%
(23)
-669%
(23)
0%
(19)
+18%
(9)
+51%
(7)
+20%
(7)
+11%
(10)
-55%
(20)
-95%
(25)
-26%
(27)
-9%
(31)
-13%
(7)
+77%
(17)
-131%
(15)
+8%
(14)
+9%
(14)
+1%
(12)
+13%
(13)
-8%
(12)
+5%
(7)
+44%
(10)
-42%
(13)
-35%
(16)
-24%
(16)
-2%
(13)
+18%
(7)
+45%
Net Income
Tax Provision
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
(1)
(1)
1
3
2
2
0
0
0
0
2
2
1
1
1
1
2
2
1
0
(0)
(2)
Income from Continuing Operations
(5)
(7)
(11)
(3)
(37)
(26)
(28)
(28)
(23)
(25)
(17)
4
4
(1)
(3)
(23)
(23)
(19)
(11)
(9)
(8)
(9)
(17)
(23)
(25)
(31)
(7)
(16)
(15)
(12)
(12)
(11)
(12)
(12)
(6)
(8)
(11)
(15)
(16)
(14)
(9)
Net Income (Common)
(5)
N/A
(7)
-41%
(11)
-66%
(3)
+73%
(37)
-1 093%
(26)
+30%
(28)
-6%
(28)
-3%
(23)
+19%
(25)
-8%
(17)
+32%
4
N/A
4
-9%
(1)
N/A
(3)
-103%
(23)
-669%
(23)
0%
(19)
+18%
(11)
+42%
(9)
+19%
(8)
+10%
(9)
-16%
(17)
-86%
(23)
-32%
(25)
-10%
(31)
-23%
(7)
+77%
(16)
-136%
(15)
+10%
(12)
+21%
(12)
+0%
(11)
+4%
(12)
-5%
(12)
+3%
(6)
+50%
(8)
-30%
(11)
-48%
(15)
-31%
(16)
-9%
(14)
+14%
(9)
+35%
EPS (Diluted)
-61.12
N/A
-98.28
-61%
-162.99
-66%
-44.28
+73%
-528.14
-1 093%
-371.71
+30%
-393.57
-6%
-404.14
-3%
-328.42
+19%
-354.71
-8%
-240.85
+32%
54.24
N/A
56.71
+5%
-20.71
N/A
-42.14
-103%
-323.99
-669%
-325.14
0%
-268.14
+18%
-156.14
+42%
-49
+69%
-28.39
+42%
-38.58
-36%
-61.42
-59%
-81.17
-32%
-89.6
-10%
-118.53
-32%
-0.98
+99%
-1.88
-92%
-1.43
+24%
-1.23
+14%
-0.66
+46%
-0.66
N/A
-0.52
+21%
-0.47
+10%
-0.57
-21%
-0.23
+60%
-0.34
-48%
-0.43
-26%
-0.47
-9%
-0.38
+19%
-0.42
-11%

See Also

Discover More